Tongmeng Pharmaceutical (TLPH) launched its product anti-counterfeiting inquiry system to check its products ID. The new anti-counterfeiting system adopts "dot matrix code + QR code" anti-counterfeiting technology to achieve "one thing (box) one code" accurate anti-counterfeiting identification

Sotoraib (Sotorasib)120 mg* 120 film-coated tablets. Sotoraib (Sotorasib) is an inhibitor of the RAS GTPase family indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or or metastatic non-small cell lung cancer (NSCLC).

Cancer, hematologic malignancies patients could apply free TLPH Molavir (Molnupiravir) to lower the risk of developing severe/critical Coronavirus disease 2019 (COVID‐19).

Teponi (Tepotinib) 225 mg * 60 film-coated tablets.Teponi is a kinase inhibitor that targets MET, including valiants with exon 14 skipping alterations. Teponi inhibits hepatocyte growth factor(HGF)-dependent and -independent MET phospho¹ylation and MET-dependent downstream signaling pathways. Teponi also inhibited melatonin2 and imidazoline 1 receptors at clinically achievable concentrations.

Erdaini (erdafitinib) tablets, 3mg/4mg/5mg* 28 tablets/ bottle. Erdafitinib is a kinase inhibitor indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC)

Acaluni (acalabrutinib), capsules, the specification is 100mg* 60 capsules/bottle. Acalabrutinib is an oral BTK inhibitor,was approved for the treatment of chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia based on phase III clinical studies ELEVATE-TN and ASCEND studies Adult patients with lymphoma (SLL).